Medical hypothesis, discovery & innovation in optometry

Role of intestinal microbiome in the pathogenesis of age-related macular degeneration

Medical hypothesis, discovery & innovation in optometry, Vol. 1 No. 1 (2020), 31 August 2020 , Page 29-36
https://doi.org/10.51329/mehdioptometry105

Abstract

Background: The microbiome is strongly linked to many extra-intestinal disorders. Gut commensal microbiota, in particular, plays an active role in human immune and intestinal homeostasis. Complex interactions of the microbiota with host genetics and other underlying factors lead to intestinal dysbiosis, which is thought to be linked to ocular inflammatory diseases. Thus, the aim of this review is to analyze the role of intestinal microbiome in age-related macular degeneration (AMD).
Methods: A thorough literature search was performed using PubMed/MEDLINE, limited to English language publications, from January 2004 to March 2020. An additional search was made employing Google Scholar to complete the collected data as per the above-mentioned time-line and language limitations. The main keywords used included age-related macular degeneration, microbiome, dysbiosis, autoimmunity, gut microbiota, epigenetics, immune-mediated inflammatory diseases, and gut-retina axis.
Results: Recent studies have proposed the role of intestinal microbiota in the pathogenesis of AMD. Changes in the microbiome have been shown to trigger several ocular inflammatory processes. There is increasing evidence demonstrating that intestinal microbial imbalance may play an important role in the pathogenesis of AMD.
Conclusions: This review summarizes how alterations in the intestinal microbiota can be associated with the pathogenesis of AMD and how new therapeutic modalities can be designed to target this microbiome to limit the severe nature of this disease. Future advances in microbiome research may unveil a new era in understanding and managing AMD.
Keywords:
  • AMD
  • age-related macular degeneration
  • gastrointestinal microbiome
  • gut microbiome
  • gut flora
  • dysbiosis
  • optometry
  • ophthalmology
  • gut
  • retina

References

Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: A review. Clin Exp Ophthalmol. 2019;47(3):418-22. doi: 10.1111/ceo.13493 pmid: 30834680

Baim AD, Movahedan A, Farooq AV, Skondra D. The microbiome and ophthalmic disease. Exp Biol Med (Maywood). 2019;244(6):419-29. doi: 10.1177/1535370218813616 pmid: 30463439

Lin P. The role of the intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol. 2018;29(3):261-6. doi: 10.1097/ICU.0000000000000465 pmid: 29538183

Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41. doi: 10.1016/j.cell.2014.03.011 pmid: 24679531

Chervonsky AV. Microbiota and autoimmunity. Cold Spring Harb Perspect Biol. 2013;5(3):a007294. doi: 10.1101/cshperspect.a007294 pmid: 23457255

Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492-506.doi: 10.1038/s41422-020-0332-7 pmid: 32433595

Forbes JD, Van Domselaar G, Bernstein CN. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol.2016;7:1081. doi: 10.3389/fmicb.2016.01081 pmid: 27462309

Zinkernagel MS, Zysset-Burri DC, Keller I, Berger LE, Leichtle AB, Largiader CR, et al. Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration. Sci Rep. 2017;7:40826. doi: 10.1038/srep40826 pmid: 28094305

Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats. PLoS One. 2014;9(8):e105684. doi: 10.1371/journal.pone.0105684 pmid: 25140823

Nayyar A, Gindina S, Barron A, Hu Y, Danias J. Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence. Hum Genomics. 2020;14(1):11. doi: 10.1186/s40246-020-00257-5 pmid: 32169120

Andriessen EM, Wilson AM, Mawambo G, Dejda A, Miloudi K, Sennlaub F, et al. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med. 2016;8(12):1366-79. doi: 10.15252/emmm.201606531 pmid: 27861126

Rowan S, Taylor A. Gut microbiota modify risk for dietary glycemia-induced age-related macular degeneration. Gut Microbes. 2018;9(5):452-7. doi: 10.1080/19490976.2018.1435247 pmid: 29431583

Carneiro A, Andrade JP. Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review. Oxid Med Cell Longev. 2017;2017:6469138. doi: 10.1155/2017/6469138 pmid: 28154734

Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res. 2004;23(5):523-31. doi: 10.1016/j.preteyeres.2004.05.001 pmid: 15302349

de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355(14):1474-85. doi: 10.1056/NEJMra062326 pmid: 17021323

Zhang QY, Tie LJ, Wu SS, Lv PL, Huang HW, Wang WQ, et al. Overweight, Obesity, and Risk of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2016;57(3):1276-83. doi: 10.1167/iovs.15-18637 pmid: 26990164

Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 2008;126(11):1554-60. doi: 10.1001/archopht.126.11.1554 pmid: 19001224

Chiu CJ, Taylor A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res. 2011;30(1):18-53. doi:

1016/j.preteyeres.2010.09.001 pmid: 20868767

Rinninella E, Mele MC, Merendino N, Cintoni M, Anselmi G, Caporossi A, et al. The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut(-)Retina Axis. Nutrients. 2018;10(11). doi:10.3390/nu10111677 pmid: 30400586

Lau K, Srivatsav V, Rizwan A, Nashed A, Liu R, Shen R, et al. Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases. Nutrients. 2017;9(8). doi: 10.3390/nu9080859 pmid: 28796176

Ma J, Zhou Q, Li H. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients.2017;9(10). doi: 10.3390/nu9101124 pmid: 29035308

Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, et al. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019;69(1):107-20. doi: 10.1002/hep.30036 pmid: 29665135

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-31. doi: 10.1038/nature05414 pmid: 17183312

Adams MK, Simpson JA, Aung KZ, Makeyeva GA, Giles GG, English DR, et al. Abdominal obesity and age-related macular degeneration. Am J Epidemiol. 2011;173(11):1246-55. doi: 10.1093/aje/kwr005 pmid: 21422060

Clarke SF, Murphy EF, Nilaweera K, Ross PR, Shanahan F, O’Toole PW, et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes. 2012;3(3):186-202. doi: 10.4161/gmic.20168 pmid: 22572830

Rabot S, Membrez M, Bruneau A, Gerard P, Harach T, Moser M, et al. Germ-free C57BL/6J mice are resistant to high-fat-dietinduced insulin resistance and have altered cholesterol metabolism. FASEB J. 2010;24(12):4948-59. doi: 10.1096/fj.10-164921 pmid:20724524

Ticinesi A, Lauretani F, Milani C, Nouvenne A, Tana C, Del Rio D, et al. Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis? Nutrients. 2017;9(12). doi: 10.3390/nu9121303 pmid: 29189738

Evans J, Lawrenson J. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2017;7:CD000254. doi: 10.1002/14651858.CD000254.pub4 pmid: 28756618

Abd A, Kanwar R, Kanwar J. Aged macular degeneration: current therapeutics for management and promising new drug candidates. Drug Discov Today. 2017;22(11):1671-9. doi: 10.1016/j.drudis.2017.07.010 pmid: 28782687

Ahmadi M, Gharibi T, Dolati S, Rostamzadeh D, Aslani S, Baradaran B, et al. Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases. Biomed Pharmacother. 2017;87:596-608. doi: 10.1016/j.biopha.2016.12.072 pmid: 28086135

Ramadoss M, Mahadevan V. Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors. Drug Discov Today. 2018;23(1):76-89. doi: 10.1016/j.drudis.2017.09.011 pmid: 28943305

Cheung K, Lu G, Sharma R, Vincek A, Zhang R, Plotnikov AN, et al. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci U S A. 2017;114(11):2952-7. doi: 10.1073/pnas.1615601114 pmid: 28265070

Eskandarpour M, Alexander R, Adamson P, Calder VL. Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells. J Immunol. 2017;198(3):1093-103. doi: 10.4049/jimmunol.1600735 pmid: 28039300

Hammitzsch A, Tallant C, Fedorov O, O’Mahony A, Brennan PE, Hay DA, et al. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proc Natl Acad Sci U S A. 2015;112(34):10768-73. doi: 10.1073/pnas.1501956112 pmid: 26261308

Wen X, Hu X, Miao L, Ge X, Deng Y, Bible PW, et al. Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye. Prog Retin Eye Res. 2018;64:84-95. doi: 10.1016/j.preteyeres.2018.01.001 pmid: 29357307

Markowiak P, Slizewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9). doi: 10.3390/nu9091021 pmid: 28914794

Gilbert JA, Quinn RA, Debelius J, Xu ZZ, Morton J, Garg N, et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535(7610):94-103. doi: 10.1038/nature18850 pmid: 27383984

Zegans ME, Van Gelder RN. Considerations in understanding the ocular surface microbiome. Am J Ophthalmol. 2014;158(3):420-2.doi: 10.1016/j.ajo.2014.06.014 pmid: 25132249

Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408-13. doi: 10.1167/iovs.10-6939 pmid: 21571682

Lu LJ, Liu J. Human Microbiota and Ophthalmic Disease. Yale J Biol Med. 2016;89(3):325-30. pmid: 27698616

Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, et al. The Microbiome and Human Biology. Annu Rev Genomics Hum Genet. 2017;18:65-86. doi: 10.1146/annurev-genom-083115-022438 pmid: 28375652

  • Abstract Viewed: 411 times
  • Full Text PDF Downloaded: 0 times

Download Statastics

Make a Submission
Information